# EDGAR Filing Document

**Accession Number:** 0001538495
**File Stem:** 0001641172-25-016721
**Filing Date:** 2025-6
**Character Count:** 30172
**Document Hash:** 3e3012d8a2db74d5a9f1a9a1e8e32bf4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-016721.hdr.sgml**: 20250627

**ACCESSION NUMBER**: 0001641172-25-016721

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 46

**CONFORMED PERIOD OF REPORT**: 20250626

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250627

**DATE AS OF CHANGE**: 20250626

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Earth Science Tech, Inc.
- **CENTRAL INDEX KEY:** 0001538495
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 454267181
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55000
- **FILM NUMBER:** 251081767

**BUSINESS ADDRESS:**
- **STREET 1:** 8950 SW 74TH CT
- **STREET 2:** SUITE 101
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33156
- **BUSINESS PHONE:** (786) 375-7281

**MAIL ADDRESS:**
- **STREET 1:** 8950 SW 74TH CT
- **STREET 2:** SUITE 101
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33156

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ultimate Novelty Sports Inc.
- **DATE OF NAME CHANGE:** 20111230

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **June 26, 2025**

Commission File No. 000-55000

**<u>EARTH SCIENCE TECH, INC.</u>**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **florida** | **45-4267181** |
| (State or other jurisdiction | (I.R.S. Employer |
| of incorporation or organization) | Identification No.) |

---

**<u>8950 SW 74 <sup>th</sup> CT</u>**

**<u>Suite 1401</u>**

**<u>Miami, FL 33156, USA</u>**

(Address of principal executive offices, zip code)

**<u>(305) 724-5684</u>**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(g) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock $0.001 par value | ETST | Over the Counter Bulletin Board |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02 Results of Operations and Financial Condition** 

On June 26, 2025, Earth Science Tech, Inc., a Florida corporation (the "Company"), issued a press release announcing its financial results and condition as of and for the fiscal year ended March 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1. Additionally, a presentation summarizing the Company's financial results for the same period is furnished herewith as Exhibit 99.2.

Exhibits 99.1 and 99.2 contain certain financial information that has not been prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"), including references to non-GAAP financial measures and forward-looking financial guidance. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in the data tables at the end of each exhibit. These non-GAAP financial measures are presented as supplemental information and should not be considered a substitute for, or superior to, the financial measures prepared in accordance with GAAP.

The information contained in this Item 2.02, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference in such filing.

**Item 7.01 Regulation FD Disclosure** 

The information set forth in Item 2.02 above is incorporated by reference into this Item 7.01 in its entirety.

**Item 9.01. Financial Statements and Exhibits.**

(d) *Exhibits* – The following exhibits are filed as part of this report:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [Press release dated June 26, 2025](ex99-1.htm) |
| 99.2 | [March 31, 2025, Financials Results Presentation](ex99-2.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **EARTH SCIENCE TECH, INC.** | **EARTH SCIENCE TECH, INC.** |
| **Dated: June 26, 2025** | **By:** | ***/s/ Giorgio R. Saumat*** |
|  |  | Giorgio R. Saumat |
|  | **Its:** | **CEO and Chairman of the Board** |

---

## Exhibit 99.1

**Exhibit 99.1**

**Earth Science Tech, Inc. Reports Fiscal Year-End Results for March 31, 2025, with Revenue Exceeding $33.1 Million and Net Profit of $3.2 Million**

Miami, FL, June 26, 2025, Earth Science Tech, Inc. (OTC: ETST) ("ETST" or "Company"), a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses, today shares its financial results for the year ended March 31, 2025.

<u>For the fiscal year ended March 31, 2025, the Company reported the following results</u>:

**●** **Cash:** $1,473,228, compared to $697,721 as of March 31, 2024—an increase of $775,507, representing a 111.15% year-over-year improvement.

● **Total Assets:** $7,066,721, compared to $3,881,336 as of March 31, 2024—an increase of $3,185,385, representing an 82.07% year-over-year improvement.

● **Revenue:** $33,117,624, compared to $11,953,635 for the year ended March 31, 2024—an increase of $21,163,989, representing a 177.05% year-over-year improvement.

● **Gross Profit:** $24,300,136, compared to $7,828,496 for the year ended March 31, 2024—an increase of $16,471,640, representing a 210.41% year-over-year improvement.

● **Net Profit:** $3,253,635, compared to $812,139 for the year ended March 31, 2024—an increase of $2,441,496, representing a 300.63% year-over-year improvement.

● **Outstanding Shares:** 295,347,903 shares of common stock issued and outstanding, compared to 309,981,819 shares as of March 31, 2024—a reduction of 14,633,916 shares, representing a 4.72% decrease in shares outstanding.

**About Earth Science Tech, Inc.** 

Earth Science Tech, Inc. operates as a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The Company's current operations include compounding pharmaceuticals, telemedicine and real estate development through its wholly owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC ("Mister Meds"), and Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC., and an 80% interest in MagneChef.

To learn more, please visit: <u>www.EarthScienceTech.com</u>

**RxCompoundStore.com, LLC.**

RxCompoundStore.Com, based in Miami, Florida, is a fully licensed compounding pharmacy authorized to fulfill prescriptions in the following states and territories: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Maine, Maryland, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Utah, Wisconsin and Puerto Rico. RxCompound is actively pursuing licensure in the remaining U.S. states.

To learn more please visit: <u>www.RxCompoundStore.com</u>

**MisterMeds, LLC.**

Mister Meds, acquired on October 1, 2024, is in Abilene, Texas. The pharmacy received full compounding licensure in March 2025. It operates out of a 5,000 sq. ft. facility owned by Avenvi and includes advanced sterile compounding capabilities with both positive and negative pressure environments, as well as hazardous drug handling. Mister Meds is currently applying for licensure in states not yet serviced by RxCompound.

To learn more please visit: <u>www.mistermeds.com</u>

**Peaks Curative, LLC.**

Peaks is a telemedicine referral platform offering asynchronous consultations for Peaks-branded compounded medications prepared at RxCompound and Mister Meds. The platform operates in states where either pharmacy is licensed. Through the development of its own healthcare provider network, MyOnlineConsultation.com, and ongoing licensure expansion for both pharmacies, Peaks aims to offer services nationwide. In addition, the company has recently expanded into the veterinary market through the acquisition of Zoolzy.com.

To learn more please visit: <u>www.PeaksCurative.com</u>

**Las Villas Health Care, Inc.**

Las Villas is a brick-and-mortar healthcare facility dedicated to the Spanish speaking community. Our expert-led services include advanced sexual health treatments, and customized solutions to enhance physical performance. We combine compassionate, personalized care with clear, trustworthy education—empowering you to take control of your health with confidence.

To learn more please visit: <u>https://villashealth.com</u>

**Doconsultation.com, LLC.**

Doconsultation was born with a passion to modernize the availability and delivery of home therapies. DOConsultations providers tailor a medication plan around your health and wellness goals and follow up with our patients to ensure results, while our partner pharmacies conveniently ship directly to your door.

To learn more please visit: <u>https://doconsultations.com/</u>

**Avenvi, LLC.**

Avenvi is a diversified real estate company engaged in development, asset management, and financing. With a growing portfolio of real estate holdings, Avenvi provides turnkey solutions from development to end-user financing. It also manages investment activities for ETST and oversees the Company's ongoing $5 million share repurchase program.

To learn more please visit: <u>www.avenvi.com</u>

**MagneChef**

MagneChef is a direct-to-consumer retail brand. Utilizing its patents and intellectual properties, the company aims to develop new products that can be marketed and sold online. Currently, the company has developed products for cooking. MagneChef is in the process of expanding its product line for new offerings that incorporate its intellectual property.

To learn more please visit: <u>https://magnechef.com/</u>

**About Earth Science Foundation, Inc.**

Earth Science Foundation Inc. a 501(c)(3) nonprofit organization incorporated on February 11, 2019, is the charitable arm of ETST. ESF accepts grants and donations to assist individuals who need financial support for prescription costs at both RxCompound and Mister Meds.

**SAFE HARBOR ACT:** Forward-Looking Statements. Except for historical information, the matters discussed herein may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as "expect," "expectation," "believe," "anticipate," "may," "could," "intend," "belief," "plan," "estimate," "target," "predict," "likely," "seek," "project," "model," "ongoing," "will," "should," "forecast," "outlook" or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company's actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company's products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

**Company Contact:**<br> Giorgio R. Saumat<br> CEO and Chairman of the Board<br> (305) 724-5684<br> <u>IR@earthsciencetech.com</u>

## Exhibit 99.2

**Exhibit 99.2**

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Symbol: ETST**

**Fiscal Year Ends:** March 31st

**Business Summary:**

Earth Science Tech, Inc. operates as a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The Company's current operations include compounding pharmaceuticals, telemedicine and real estate development through its wholly owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC ("Peaks"), Avenvi, LLC, Mister Meds, LLC, and Earth Science Foundation, Inc. Subsequent to the reporting period, the Company acquired 100% of Las Villas Health Care, Inc., DOConsultations, LLC, and an 80% interest in MagneChef.

---

| | | | |
|:---|:---|:---|:---|
| **Executives:** | **Executives:** | **Board Of Directors:** | **Board Of Directors:** |
| ● | Giorgio R. Saumat - CEO | ● | Giorgio R. Saumat - Chairman |
| ● | Mario G. Tabraue - COO | ● | Mario G. Tabraue - Director |
| ● | Ernesto L. Flores - CFO / Treasurer | ● | Yovan Sanchez - Director |
| ● | Christopher Rose - CTO | ● | Jeff P.H. Cazeau, JD - Independent Director |
| ● | Victoria Losada - Secretary | ● | Emiliano Curia, MD - Independent Director |
|  |  | ● | Ernesto L. Flores - Director |
| **Audit Committee:** | **Audit Committee:** | ● | Victoria Losada - Director |
| ● | Jeff P.H. Cazeau - Chairman |  |  |
| ● | Emiliano Curia, MD |  |  |
| ● | Ernesto L. Flores | **Auditing Firm:** | **Auditing Firm:** |
|  |  |  | Stephano Slack, LLC |
| **Compensation Committee:** | **Compensation Committee:** |  | 125 Strafford Avenue, Suite 200 |
| ● | Ernesto L. Flores - Chairman |  | Wayne, Pennsylvania 19087 |
| ● | Victoria Losada |  |  |
| ● | Emiliano Curia, MD | **Securities Counsel:** | **Securities Counsel:** |
|  |  |  | Carl P. Rano, Esq. |
| **Contact Information:** | **Contact Information:** |  | 2733 East Vista Drive |
|  | Giorgio R. Saumat |  | Phoenix, Arizona 85032 |
|  | CEO and Chairman of the Board |  |  |
|  |  | **Transfer Agent:** | **Transfer Agent:** |
|  | 8950 SW 74th CT |  | Continental Stock Transfer and Trust |
|  | Suite 1401 |  | 1 State Street, 30th Floor |
|  | Miami, FL 33156 |  | New York, New York 10004-1561 |
|  | (305) 724-5684 | **Website:** | **Website:** |
|  | IR@EarthScienceTech.com |  | <u>http://www.EarthScienceTech.Com</u> |

---

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Safe Harbor**

***Forward-Looking Statements.*** *Except for historical information, the matters discussed herein may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.*

 

*Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as "expect," "expectation," "believe," "anticipate," "may," "could," "intend," "belief," "plan," "estimate," "target," "predict," "likely," "seek," "project," "model," "ongoing," "will," "should," "forecast," "outlook" or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company's actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company's products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.*

June 25th, 2025

**Brief History**

Founded on April 23, 2010, the company faced major challenges, including a $4 million judgment in the CBD sector that led to receivership. In a bid to recover, it acquired two small businesses—RxCompoundStore.com (RXCS) and Peaks Curative (PEAKS)—from Mario Guillermo Tabraue, now COO, via a debt note.

To exit receivership, the company needed funding and a repayment plan. Tabraue turned to longtime friend Giorgio R. Saumat, who offered a $350,000 convertible note. However, the company struggled under its debt and was near bankruptcy by September 2022.

On September 30, after a critical conversation, Saumat agreed to step in under strict terms: full control of Series B Preferred Stock, conversion of all partner debts to equity, direct negotiations with creditors, and appointment as Chairman. Tabraue agreed, and within a week, Saumat had secured most outstanding debt and converted it into equity.

From late 2022 into 2023, Saumat and Tabraue focused on building RXCS and relaunching PEAKS. Saumat became CEO in February 2023, and by mid-year, the company saw strong growth, expanded operations, and cleared all debt by December.

In 2024, RXCS and PEAKS thrived, and on October 1, the company acquired Mister Meds and Avenvi to further boost value. Subsequent to the reporting period, in April, 2025, the Company acquired 100% of Las Villas Health Care, Inc., DOConsultations, LLC, and an 80% interest in MagneChef.

June 25th, 2025

**Capital Structure**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **As of:** | **12/31/2023** | **03/31/2024** | **06/30/2024** | **09/30/2024** | **12/31/2024** | **03/31/2025** |
| **Authorized** | 750000000 | 350000000 | 350000000 | 350000000 | 350000000 | 350000000 |
| **Outstanding** | 314850730 | 309981819 | 309050711 | 303635893 | 302664571 | 295347903 |
| **Float** | 31944230 | 37634230 | 38071051 | 36796263 | 36440296 | 36440296 |

---

**As of June 20th, 2025: O/S Shares: 294,297,607 Float: 35,390,000**

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Subsidiaries**

RxCompoundStore.Com, based in Miami, Florida, is a fully licensed compounding pharmacy authorized to fulfill prescriptions in the following states and territories: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Maine, Maryland, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Utah, Wisconsin and Puerto Rico. RxCompound is actively pursuing licensure in the remaining U.S. states.

Mister Meds, acquired on October 1, 2024, is in Abilene, Texas. The pharmacy received full compounding licensure in March 2025. It operates out of a 5,000 sq. ft. facility owned by Avenvi and includes advanced sterile compounding capabilities with both positive and negative pressure environments, as well as hazardous drug handling. Mister Meds is currently applying for licensure in states not yet serviced by RxCompound.

&nbsp;&nbsp;<br>![A purple and black logo AI-generated content may be incorrect.](ex99-2_016.jpg)<br>

June 25th, 2025

Peaks is a telemedicine referral platform offering asynchronous consultations for Peaks-branded compounded medications prepared at RxCompound and Mister Meds. The platform operates in states where either pharmacy is licensed. Through the development of its own healthcare provider network, MyOnlineConsultation.com, and ongoing licensure expansion for both pharmacies, Peaks aims to offer services nationwide. In addition, the company has recently expanded into the veterinary market through the acquisition of Zoolzy.com.

![](ex99-2_022.jpg)

DOConsultation was born with a passion to modernize the availability and delivery of home therapies. DOConsultations providers tailor a medication plan around your health and wellness goals and follow up with our patients to ensure results, while our partner pharmacies conveniently ship directly to your door.

![A logo with blue text AI-generated content may be incorrect.](ex99-2_023.jpg)

Las Villas is a brick-and-mortar healthcare facility dedicated to the Spanish speaking community. Our expert-led services include advanced sexual health treatments, and customized solutions to enhance physical performance. We combine compassionate, personalized care with clear, trustworthy education—empowering you to take control of your health with confidence.

Avenvi is a diversified real estate company engaged in development, asset management, and financing. With a growing portfolio of real estate holdings, Avenvi provides turnkey solutions from development to end-user financing. It also manages investment activities for ETST and oversees the Company's ongoing $5 million share repurchase program.

![A black background with white text AI-generated content may be incorrect.](ex99-2_025.jpg)

MagneChef is a direct-to-consumer retail brand. Utilizing its patents and intellectual properties, the company aims to develop new products that can be marketed and sold online. Currently, the company has developed products for cooking. MagneChef is in the process of expanding its product line for new offerings that incorporate its intellectual property.

Earth Science

Foundation

Earth Science Foundation Inc. a 501(c)(3) nonprofit organization incorporated on February 11, 2019, is the charitable arm of ETST. ESF accepts grants and donations to assist individuals who need financial support for prescription costs at both RxCompound and Mister Meds.

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Financial Performance**

**Annual Revenue (In Millions)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Period ended:** | **3/31/2023** | **3/31/2023** | **3/31/2024** | **3/31/2024** | **3/31/2025** | **3/31/2025** |
|  |  | .04 |  | 11.95 |  | 33.11 |

---

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Annual Gross Profit (In Millions)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Period ended:** | **3/31/2023** | **3/31/2023** | **3/31/2024** | **3/31/2024** | **3/31/2025** | **3/31/2025** |
|  |  | .02 |  | 7.82 |  | 24.3 |

---

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Annual Total Assets (In Millions)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Period ended:** | **3/31/2023** | **3/31/2023** | **3/31/2024** | **3/31/2024** | **3/31/2025** | **3/31/2025** |
|  |  | 2.72 |  | 3.88 |  | 7.06 |

---

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Annual Stockholders' Equity (In Millions)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Period ended:** | **3/31/2023** | **3/31/2023** | **3/31/2024** | **3/31/2024** | **3/31/2025** | **3/31/2025** |
|  |  | 1.11 |  | 2.24 |  | 3.85 |

---

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Annual Cash (In Millions)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Period ended:** | **3/31/2023** | **3/31/2023** | **3/31/2024** | **3/31/2024** | **3/31/2025** | **3/31/2025** |
|  |  | 0.035 |  | 0.69 |  | 1.47 |

---

**![Points scored](ex99-2_035.jpg)<br>** 

<br> June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Annual Employee Count Across All Subsidiaries**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Period ended:** | **3/31/2023** | **3/31/2023** | **3/31/2024** | **3/31/2024** | **03/31/2025** | **03/31/2025** |
|  |  | 13 |  | 36 |  | 76 |

---

June 25th, 2025

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Projections (In Millions)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **FY Ending:** | **3/31/2023**<br> **(Actual)** | **3/31/2024**<br> **(Actual)** | **3/31/2025**<br> **(Actual)** |  |
| **Revenue\*** | 0.048 \* | 11.953 \* | 33.11 | \* |
| **Cash/Equivalents\*** | 0.0313 \* | 0.0316 \* | 2.17 | \* |
| **Cash(Equiv)/Share** | $0.000 | $0.000 | $0.007 | \*\* |
| **EPS** | $-0.003 | $.003 | $0.011 | \*\* |
| **P/E Ratio** | 0 | 22.33 | 13.64 | \*\* |

---

*\*In Millions*

*\*\*Based on Current Price of $0.15 & Current O/S Count of 294,297,607 shares*

June 25th, 2025

![](ex99-2_044.jpg)

*\*Based on Current O/S Count of 294,297,607 shares*

 

June 25th, 2025

 

![](ex99-2_045.jpg)

 

*\*Based on Current Price of $0.12 & Current O/S Count of 294,297,607 shares*

 

![Points scored](ex99-2_043.jpg)

*\*Based on Current Price of $0.12 & Current O/S Count of 294,297,607 shares*

June 25th, 2025

 

![A black background with red text AI-generated content may be incorrect.](ex99-2_001.jpg)

**Notable Events**

---

| | |
|:---|:---|
| **Date** | **News/Disclosure** |
| **05/06/2025** | **8-K: ETST Shares Annual Letter From The CEO** |
| **04/07/2025** | **8-K: ETST Completes Acquisitions and engages new Audit Firm** |
| **03/19/2025** | **8-K: ETST Extends Employment Agreement with CFO and CTO** |
| **03/11/2025** | **8-K: ETST Amends Acquisition Agreement for Las Villas Healthcare, LLC and DOConsultations.Com, LLC** |
| **02/14/2025** | **10-Q: ETST Files 3rd Quarter Earnings Report (Unaudited)** |
| **02/04/2025** | **8-K: ETST Agrees to Acquire Las Villas Healthcare, LLC; DOConsultaions.Com, LLC and Magnefuse, LLC** |
| **12/30/2024** | **8-K: ETST Expands Board of Directors to 7 Members, Creates Compensation Committee and Renegotiates Executive Compensation for CEO and COO** |
| **11/14/2024** | **10-Q: ETST Files 2nd Quarter Earnings Report (Unaudited)** |
| **10/07/2024** | **8-K: ETST Acquires Avenvi, LLC, Mister Meds, LLC and Zoolzy.Com** |
| **07/29/2024** | **10-Q: ETST Files 1st Quarter Earnings Report (Unaudited)** |
| **06/28/2024** | **10-K: ETST Files FY Ending March 31st, 2024 Annual Report (Audited)** |
| **04/29/2024** | **8-K: ETST Shares Annual Letter From The CEO** |
| **04/19/2024** | **8-K: ETST Hires Chief Technology Officer (CTO)** |
| **03/05/2024** | **8-K: ETST Hires New Chief Financial Officer (CFO)** |
| **02/21/2024** | **8-K: ETST Engages New Auditor - Assurance Dimensions** |
| **02/20/2024** | **8-K: ETST Files 3rd Quarter Earnings Report (Unaudited)** |
| **01/29/2024** | **8-K: ETST Board of Directors Authorizes $5 Million Share Repurchase Program** |
| **01/09/2024** | **8-K: ETST Reduces Authorized Share Count** |
| **11/13/2023** | **8-K: ETST Files 2nd Quarter Earnings Report (Unaudited)** |
| **11/08/2023** | **8-K: ETST Expands Board of Directors to 5 Members** |
| **08/09/2023** | **8-K: ETST Launches DocProtocol.Com** |
| **07/27/2023** | **8-K: ETST Files 1st Quarter Earnings Report (Unaudited)** |
| **06/20/2023** | **8-K: ETST Files FY Ending March 31st, 2023 Annual Report (Audited)** |
| **02/10/2023** | **10-Q: ETST Files 3rd Quarter Earning Report (Unaudited)** |
| **11/14/2022** | **10-Q: ETST Files 2nd Quarter Earnings Report (Unaudited)** |
| **11/08/2022** | **8-K: ETST Completes Acquisition of RxCompoundStore.Com and Peaks Curative** |
| **10/28/2022** | **8-K: ETST Settles Debt, Giorgio R. Saumat Acquires 100% of Series B Preferred Stock** |
| **08/15/2022** | **10-Q: ETST Files 1st Quarter Earnings Report (Unaudited)** |

---